Edition:
United States

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

8.05USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$8.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,555
52-wk High
$11.90
52-wk Low
$3.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.434
FY 2017 Dec '17 0.00 -0.363
Sep '17 0.00 -0.320
Jun '17 0.00 -0.351
Mar '17 0.00 -0.369
FY 2016 Dec '16 0.00 -0.370
Sep '16 0.00 -0.383
Jun '16 0.00 -0.405
Mar '16 0.00 -0.511
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.00 0.00 0.00 0.01
Year Ending Dec-19 6 0.05 0.28 0.00 4.16
Earnings (per share)
Quarter Ending Sep-18 5 -0.42 -0.34 -0.50 -0.48
Quarter Ending Dec-18 5 -0.43 -0.35 -0.48 -0.49
Year Ending Dec-18 5 -1.71 -1.52 -1.89 -1.84
Year Ending Dec-19 6 -2.12 -1.33 -3.80 -1.92
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 213.33 32.89
P/E High - Last 5 Yrs. -- 284.48 47.09
P/E Low - Last 5 Yrs. -- 97.01 24.93
Beta 0.59 0.77 0.81
Price to Sales (TTM) -- 248.72 8.00
Price to Book (MRQ) 4.40 20.99 4.21
Price to Tangible Book (MRQ) 4.50 27.14 5.98
Price to Cash Flow (TTM) -- 127.00 22.15
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.27 -6.28
Payout Ratio(TTM) -- 83.72 47.05

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.71 4.78
Sales (TTM) vs TTM 1 Yr. Ago -- 147.36 12.03
Sales - 5 Yr. Growth Rate -- 30.70 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.50 -78.08 46.97
EPS (TTM) vs TTM 1 Yr. Ago -4.67 -- --
EPS - 5 Yr. Growth Rate -- 46.73 8.00
Capital Spending - 5 Yr. Growth Rate -- 42.51 7.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.56
Current Ratio (MRQ) 11.07 6.62 3.63
LT Debt to Equity (MRQ) 3.08 24.41 13.26
Total Debt to Equity (MRQ) 3.72 28.60 17.41
Interest Coverage (TTM) -- -155.28 35.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.99 55.24
Gross Margin - 5 Yr. Avg. -- 53.44 53.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -181.72 15.63
Operating Margin (TTM) -- -949.33 -0.49
Operating Margin - 5 Yr. Avg. -- -195.36 10.78
Pre-Tax Margin (TTM) -- -844.82 1.31
Pre-Tax Margin - 5 Yr. Avg. -- -199.82 10.91
Net Profit Margin (TTM) -- -836.11 -1.97
Net Profit Margin - 5 Yr. Avg. -- -197.51 7.27
Effective Tax Rate (TTM) -- 14.81 20.76
Effective Tax Rate - 5 Yr. Avg. -- 19.06 24.28

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,353,109 735,028,818
Net Income/Employee (TTM) -- -792,586 85,698,805
Receivable Turnover (TTM) -- 17.81 5.95
Inventory Turnover (TTM) -- 2.86 3.72
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -70.94 -2.25 10.33
Return on Assets - 5 Yr. Avg. -50.85 2.92 11.01
Return on Investment (TTM) -77.45 -3.69 13.14
Return on Investment - 5 Yr. Avg. -56.02 2.72 14.23
Return on Equity (TTM) -80.15 -5.73 15.15
Return on Equity - 5 Yr. Avg. -1,184.70 -4.45 15.58
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 14.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aldeyra Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.79%
# of Holders: 61
Total Shares Held: 14,034,923
3 Mo. Net Change: 99,868
# New Positions: 4
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 1
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.